Article
PPAR-γ2 and PTPRD gene polymorphisms influence type 2 diabetes patients' response to pioglitazone in China.
Acta pharmacologica Sinica - 1 Feb 2013
Pei Qi, Huang Qiong, Yang Guo-ping, Zhao Ying-chun, Yin Ji-ye, Song Min, Zheng Yi, Mo Zhao-hui, Zhou Hong-hao, Liu Zhao-qian
Abstract excerpt
AIM: To investigate the influence of peroxisome proliferator-activated receptor γ2 (PPAR-γ2) gene polymorphism rs1801282 and protein tyrosine phosphatase receptor type D (PTPRD) gene polymorphism rs17584499 on the occurrence of type 2 diabetes and pioglitazone efficacy in a Chinese Han population. METHODS: One hundred ninety seven type 2 diabetes patients and 212 healthy controls were enrolled. Among them, 67...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
